John A Stauffer
Overview
Explore the profile of John A Stauffer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shaker A, Vasudevan S, Verastegui A, Fajardo D, Stauffer J
J Gastrointest Cancer
. 2025 Feb;
56(1):59.
PMID: 39909940
Background: Pancreaticoduodenectomy (PD) is a complex operation associated with high morbidity, especially in the setting of hepatic fibrosis/cirrhosis and portal hypertension. Portal hypertension can be a near-certain contraindication for PD,...
2.
Sadek K, Shaker A, Tice M, Stauffer J
HPB (Oxford)
. 2024 Nov;
27(1):80-86.
PMID: 39521694
Background: Limited data exists regarding the safety and outcomes of combined division of the splenic vessels with the pancreatic parenchyma during laparoscopic distal pancreatectomy (LDP). This study aims to evaluate...
3.
Asbun D, Stauffer J, Asbun H
J Gastrointest Oncol
. 2024 Sep;
15(4):1827-1835.
PMID: 39279960
Background: Laparoscopic distal pancreatectomies (LDP) confer benefits over open distal pancreatectomies (ODP). These benefits extend to patients with known malignancies. Despite being a common procedure for pancreatic surgeons, widespread adoption...
4.
Mount J, Stauffer J
J Gastrointest Oncol
. 2024 Sep;
15(4):2019-2021.
PMID: 39279942
No abstract available.
5.
Silver C, De la Garza-Ramos C, Stauffer J, Majeed U, Wang J, Toskich B
Radiol Case Rep
. 2024 Sep;
19(11):5024-5028.
PMID: 39247469
Unresectable hepatocellular carcinoma unresponsive to first-line immunotherapy has a poor prognosis with modest response to tyrosine kinase inhibitors in the second line. In these patients, the benefit of local therapy...
6.
Moaven O, Mainali B, Valenzuela C, Russell G, Cheung T, Corvera C, et al.
J Surg Oncol
. 2024 Aug;
130(8):1654-1661.
PMID: 39183490
Background: This study investigates the impact of margin status after colorectal liver metastasis (CLM) resection on outcomes of patients after neoadjuvant treatment versus those who underwent upfront resection. Methods: An...
7.
Mainali B, Valenzuela C, Moaven O, Stauffer J, Del Piccolo N, Cheung T, et al.
J Surg Oncol
. 2024 Aug;
130(3):516-522.
PMID: 39099202
Background: Thermal ablation has recently become a key therapy for the treatment of colorectal liver metastasis (CLM). However, the role of ablation in combination with resection has not yet been...
8.
Stauffer J, Hyman D, Porrazzo G, Tice M, Li Z, Almerey T
Surgery
. 2024 Feb;
175(4):1162-1167.
PMID: 38307785
Background: Laparoscopic pancreaticoduodenectomy has been found safe and associated with advantages over open pancreaticoduodenectomy in prior studies. We compared outcomes of laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy at a single institution...
9.
Zamorano A, Valencia P, Porrazzo G, Almerey T, Stauffer J
Langenbecks Arch Surg
. 2023 Sep;
408(1):383.
PMID: 37770715
Purpose: To compare the outcomes between patients with cirrhosis and those without who have undergone pancreatoduodenectomy (PD) in our institution. Methods: A review of patients undergoing PD from the time...
10.
Valenzuela C, Moaven O, Solsky I, Stauffer J, Del Piccolo N, Cheung T, et al.
Ann Surg Oncol
. 2023 Mar;
30(6):3413-3422.
PMID: 36859704
Introduction: Complete resection of colorectal liver metastasis (CLM) improves long-term survival in colorectal cancer. However, there is limited recent data on conditional survival (CS) as postoperative survival milestones are achieved...